• SENSEX 76,738.17
    585.31 (+0.77%)
  • BANKNIFTY 57,380.60
    208.60 (+0.36%)
  • Gland Pharma
    2,826.60 1,575.00(%)
  • Tata Technolog.
    830.10 890.15(%)
  • IFCI
    103.95 101.60(%)
  • HFCL
    231.40 257.00(%)
  • Lumino Inds
    122.00 119.00(%)
  • Jindal Worldwide
    57.06 47.55(%)
  • Netweb Technol.
    5,424.00 5,810.00(%)
  • Angel One
    308.20 360.20(%)
  • HBL Engineering
    723.85 1,121.95(%)
  • Multi Comm. Exc.
    3,257.00 3,479.80(%)
  • Adani Total Gas
    620.85 859.70(%)
  • Lenskart Solut.
    694.75 680.95(%)
  • Oberoi Realty
    1,932.25 1,985.00(%)
  • RBL Bank
    413.50 410.45(%)
  • Tejas Networks
    613.50 644.75(%)
  • Polycab India
    8,308.55 6,660.50(%)
  • Antelopus Selan
    986.05 357.00(%)
  • Nuvoco Vistas
    353.50 477.35(%)
  • One 97
    1,691.50 1,732.00(%)
  • Reliance Industries
    1,332.30 1,611.20(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Procter & Gamble Health Ltd Pharmaceuticals - Multinational

  • MNC Associate
  • BSE Code : 149.0
  • ISIN : INE199A01012
5,757.50 88 (1.55%)
  • As on 04 Sep 2026 (EOD)

  • Today’s Low

    5,646.00

  • Today’s High

    5,773.00

  • Open

    5,680.00

  • Perv Close

    5,669.50

  • 52W Low

    4,707.00

  • 52W High

    6,975.00

Key Indicators

  • P/E(TTM)

    28.71

  • Mar.Cap (₹Cr.)

    9,557.09

  • Div & Yield %

    3.56

  • Book Value(₹)

    316.01

  • Debt-Equity Ratio

    1.55

  • AGM Date

    03-Sep-2026

  • EPS

    200.73

  • P/E Ratio

    28.71

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    9,557.09

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    16.60

  • BV (₹)

    316.00

  • Sales( ₹ in Cr.)

    1,567.29

  • NP (in Cr.)

    328.30

  • NP Var(%)

    40.0

  • Div%

    2050.0

  • CPS (₹)

    212.00

  • EPS (₹)

    197.80

  • Traded Value (₹ in Lakhs)

    9,564.90

  • 52 Week High

    6,975.00

  • 52 Week Low

    4,707.00

  • Price BSE

    5762.0

  • Price NSE

    5,758.00

  • Market Capital( in Cr.)

    9,564.90

  • P/C Ratio

    27.20

  • P/E Ratio

    29.10

  • Price Vs.BV

    197.80

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Jun 2023 Jun 2022 Jun 2021 Jun
INCOME :            
Sales Turnover 1,567.29 1,029.07 1,151.26 1,229.62 1,114.41 1,008.73
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 1,567.29 1,029.07 1,151.26 1,229.62 1,114.41 1,008.73
Other Income 17.34 10.35 15.63 18.39 13.19 18.10
Stock Adjustments 12.83 -14.75 -0.87 -2.85 4.75 -1.73
Total Income 1,597.46 1,024.67 1,166.02 1,245.16 1,132.35 1,025.10
EXPENDITURE :            
Raw Materials 377.91 247.75 329.69 358.99 344.55 310.39
Power and Fuel Cost 7.33 5.82 8.50 12.88 14.70 12.97
Employee Cost 222.56 142.06 215.16 206.17 167.56 153.66
Other Manufacturing Expenses 106.16 55.91 83.99 90.86 98.43 90.82
Selling and Administration Expenses 387.77 230.88 181.66 196.86 203.91 173.99
Miscellaneous Expenses 21.73 13.51 45.58 36.33 22.33 19.15
Employee Benefit Expenses 222.56 142.06 215.16 206.17 167.56 153.66
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 1,123.46 695.93 864.58 902.09 851.48 760.98
Operating Profit 474.00 328.74 301.44 343.07 280.87 264.12
Interest 0.55 0.43 0.72 0.77 0.42 0.80
Gross Profit 473.45 328.31 300.72 342.30 280.45 263.32
Depreciation 23.59 16.69 27.40 28.10 27.08 30.04
Profit Before Tax 449.86 311.62 273.32 314.20 253.37 233.28
Current Tax 118.49 77.70 80.94 89.79 60.81 63.60
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 4.46 -0.49 -8.60 -5.06 0.04 -7.12
Reported Net Profit 326.91 234.41 200.98 229.47 192.52 176.80
Extraordinary Items -1.39 -0.10 -14.71 0.51 -0.40 -0.31
Adjusted Net Profit 328.30 234.51 215.69 228.96 192.92 177.11
Adjustment below Net Profit -0.70 -3.57 0.67 -1.84 0.70 0.42
P & L Balance brought forward 159.93 157.57 370.91 237.07 327.70 532.26
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 338.83 228.48 414.99 93.79 283.85 381.78
P & L Balance carried down 147.31 159.93 157.57 370.91 237.07 327.70
Dividend 265.58 132.80 331.99 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 2,050.00 1,250.00 2,600.00 950.00 525.00 1,300.00
Dividend Per Share(Rs) 205.00 125.00 260.00 95.00 52.50 130.00
Earnings Per Share-Unit Curr 196.93 188.28 121.07 138.23 115.98 106.51
Earnings Per Share(Adj)-Unit Curr 196.93 188.28 121.07 138.23 115.98 106.51
Book Value 315.99 323.47 324.24 452.34 371.38 423.92
Book Value(Adj)-Unit Curr 315.99 323.47 324.24 452.34 371.38 423.92

Shareholding Pattern

  • Promoter Group

    51.82%

  • Public Share Holding

    48.18%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 8,601,071 51.82 8,601,071 1
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 8,601,071 51.82 8,601,071 1
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 0 0.00 0 0
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 0 0.00 0 0
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 665 0.00 201 4
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 1,050,797 6.33 1,050,797 116
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 535,512 3.23 535,512 4
Mutual Funds / UTI 1,502,126 9.05 1,500,926 12
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 26,189 0.16 26,189 5
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 3,115,289 18.77 3,113,625 141
2] Non Institution
Bodies Corporate 397,297 2.39 394,332 461
Clearing Members 2,080 0.01 2,080 4
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 416,138 2.51 416,028 2,308
Foreign Non Institution Other 81 0.00 81 1
Hindu Undivided Families 93,314 0.56 93,314 1,188
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 325,730 1.96 325,730 7
Individuals holding nominal share capital up to Rs. 1 lakh 3,585,879 21.60 3,500,115 44,939
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 1,064 0.01 1,064 5
Others 61,439 0.37 61,439 1
Sub Total 4,883,022 29.42 4,794,183 48,914
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 16,599,382 100.00 16,508,879 49,056

Company Background

Procter & Gamble Health LtdPharmaceuticals - Multinational

  • Procter & Gamble Health Ltd
  • BSE Code : 149.0
  • ISIN : INE199A01012

  • Incorporation Year

    1967

  • Registered Office

    Godrej One 8th Floor
    Projshanagar Vikhroli (East), Mumbai,
    Maharashtra-400079

  • Telephone

    91-22-62109000

  • FAX

    91-22-62109999

  • Chairman

    MADHAVAN SAMPATH

  • Managing Director

  • Company Secretary

    Zeal Shah

  • Auditor

    Haribhakti & Co LLP

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    KFin Techologies Ltd
    Karvy Selenium Tow-B,
    31&32 Financial Dist,Nanakramguda
    Mumbai - Hyderabad-500032

Procter & Gamble Health Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Abbott India 25,878.50 7,217.19 6,929.05 34.06 43.78
Astrazeneca Phar 6,946.95 2,304.07 2,275.58 102.39 27.86
Glaxosmi. Pharma 2,935.35 3,932.76 3,790.20 46.89 58.17
Novartis India 1,614.95 398.23 356.27 40.78 16.64
Cipla 1,389.00 20,102.60 18,979.95 36.50 13.88
Bliss GVS Pharma 636.90 773.53 729.81 59.14 12.51
Amrutanjan Healt 507.20 520.13 502.55 27.17 24.16
Fermenta Biotec. 502.80 474.15 450.25 23.47 18.77
Guj. Themis Bio. 425.00 152.47 150.80 113.64 27.21
Ambalal Sarabhai 43.88 19.52 3.94 81.26 6.77